Humans deficient in CD27 (van Montfrans et al., 2012) or CD70 (Izawa et al., 2017) are at risk of lymphoproliferative disorders associated with Epstein-Barr virus (EBV) as a result of reduced proliferation of EBV-specific T cells. Here, CD70 is linked to lymphoproliferative syndrome.